Related Experiment Video
Updated: Aug 10, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
The vasculopathy of Raynaud's phenomenon and scleroderma
Nicholas A Flavahan1, Sheila Flavahan, Srabani Mitra
1Heart and Lung Research Institute, Ohio State University, 473 West 12th Avenue, Columbus OH 43210, USA. flavahan.1@osu.edu
Abstract:
The scleroderma (SSc) disease process involves dramatic dysfunction in acute and chronic vascular regulatory mechanisms; it presents initially with heightened vasoconstrictor or vasospastic activity and progresses to structural derangement or vasculopathy of the microcirculation. This article discusses the regulatory mechanisms that contribute to this dysfunction and the vascular changes in the context of the other aspects of the SSc disease process in a novel attempt to integrate the individual pathologies of the disease process.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

